Breast cancer (BC) is a highly heterogeneous disease and can be divided into four or five different subtypes according to hormone receptor (HR) and human epidermal growth factor 2 (HER2) status [1, 2]. This evidence concerns the gene ERBB2 and breast carcinoma.